`Date filed: December 4, 2014
`
`Filed On Behalf Of:
`
`Novartis AG and LTS Lohmann Therapie-Systeme AG
`
`By:
`
`Raymond R. Mandra
`ExelonPatchIPR@fchs.com
`(212) 218-2100
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`NOVARTIS AG AND LTS LOHMANN THERAPIE-SYSTEME AG,
`Patent Owners
`
`Inter Partes Review No. 2015-00268
`
`U.S. Patent 6,335,031
`
`PATENT OWNERS’ MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8(a)(2)
`
`
`
`REAL PARTY-IN-INTEREST PURSUANT TO 37 C.F.R. § 42.8(b)(1)
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(a)(2), the undersigned
`
`states that Novartis AG (“Novartis”) and LTS Lohmann Therapie-Systeme AG
`
`(formerly LTS Lohmann Therapie-Systeme GmbH Co. KG) (“LTS”) are the Patent
`
`Owners and real parties-in-interest in IPR2015-00268 directed to U.S. Patent No.
`
`6,335,031 (“the ’031 Patent”).
`
`RELATED MATTERS PURSUANT TO 37 C.F.R. § 42.8(b)(2)
`
`The ’031 Patent is being asserted in the following patent infringement
`
`lawsuits: (1) Novartis Pharm. Corp. et al. v. Par Pharm. Inc. et al., 1:11-cv-01077
`
`(D. Del.); (2) Novartis Pharm. Corp. et al. v. Watson Labs. Inc. et al., 1:11-cv-
`
`01112 (D. Del.); (3) Novartis Pharm. Corp. et al. v. Actavis, Inc. et al., 1:13-cv-
`
`00371 (D. Del.); (4) Novartis Pharm. Corp. et al. v. Noven Pharm. Inc. et al., 1:13-
`
`cv-00527 (D. Del.); (5) Novartis Pharm. Corp. et al. v. Par Pharm. Inc., 1:13-cv-
`
`01467 (D. Del.); (6) Novartis Pharm. Corp. et al. v. Noven Pharm. Inc., 1:14-cv-
`
`00111 (D. Del.); (7) Novartis Pharm. Corp. et al. v. Mylan Inc. et al., 1:14-cv-
`
`00777 (D. Del.); (8) Novartis Pharm. Corp. et al. v. Mylan Inc. et al., 1:14-cv-
`
`00106 (N.D.W.V.); (9) Novartis Pharm. Corp. et al. v. Zydus Noveltech Inc. et al.,
`
`1:14-cv-01104 (D. Del.); (10) Novartis Pharm. Corp. et al. v. Zydus Noveltech Inc.
`
`et al., 1:14-cv-05405 (D.N.J.); (11) Watson Labs. Inc. et al. v. Novartis Pharm.
`
`Corp. et al., 14-1799 (C.A.F.C.); (12) Novartis Pharm. Corp. et al. v. Par Pharm.
`
`1
`
`
`
`Inc. et al., 15-1061 (C.A.F.C.); (13) Novartis Pharm. Corp. et al. v. Par Pharm.
`
`Inc., 15-1062 (C.A.F.C.); (14) Par Pharm. Inc. v. Novartis Pharm. Corp. et al., 15-
`
`1120 (C.A.F.C.); and (15) Par Pharm. Inc. v. Novartis Pharm. Corp., 15-1121
`
`(C.A.F.C.).
`
`The ’031 Patent is being asserted in the following Inter Partes Review
`
`proceeding: Novartis Pharm. Corp. et al. v. Noven Pharm. Inc., IPR2014-00550
`
`(P.T.A.B.).
`
`IDENTIFICATION OF LEAD AND BACK-UP COUNSEL
`PURSUANT TO 37 C.F.R. §§ 42.8(b)(3) and 42.10
`
`Pursuant to 37 C.F.R. §§ 42.8(b)(3) and 42.10, Novartis and LTS designate
`
`Raymond R. Mandra (Reg. No. 34,382) as lead counsel and Nicholas N. Kallas
`
`(Reg. No. 32,530) as back-up counsel.
`
`A power of attorney from each Patent Owner is being submitted with this
`
`Notice.
`
`SERVICE INFORMATION PURSUANT TO 37 C.F.R. § 42.8(b)(4)
`
`Novartis and LTS may be served electronically using the following e-mail
`
`address:
`
`ExelonPatchIPR@fchs.com
`
`Novartis and LTS may be served by postal mailing, hand-delivery, telephone
`
`or facsimile as follows:
`
`2
`
`
`
`Raymond R. Mandra
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`
`Respectfully submitted,
`
`Dated: December 4, 2014
`
`/Raymond R. Mandra/
`Raymond R. Mandra
`Registration No. 34,382
`Lead Counsel for Patent Owners
`FITZPATRICK, CELLA, HARPER
`& SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`
`I certify that a copy of the Patent Owners’ Mandatory Notices Under 37
`
`C.F.R. § 42.8(a)(2) was served on December 4, 2014 by causing it to be sent by
`
`email to counsel for Petitioner at the following email addresses:
`
`BoxMylan2@knobbe.com
`
`Dated: December 4, 2014
`
`/Raymond R. Mandra/
`Raymond R. Mandra
`Registration No. 34,382
`FITZPATRICK, CELLA, HARPER
`& SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`FCHS_WS 10833697v1.doc
`
`4
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
